Investopedia: Medtronic Marking Time

These aren't the glory days for med-tech giant Medtronic (NYSE: MDT ), as fiscal 2014 will be a pretty weak year from a growth perspec...

Seeking Alpha: Spectranetics Has Multiple Attractive Opportunities, But Will They Execute?

I've had a love/hate relationship with Spectranetics ( SPNC ) for more than 15 years now. I've always loved the potential of the ...

Investopedia: Where Do The Bears Go Next With St. Jude Medical?

In a sell-side world where Underperform/Sell ratings are pretty rare, is a bit of exception, as several analysts have either recommended th...

Investopedia: Abbott Adds Two Promising Products

Abbott Labs (NYSE: ABT ) has never been shy about using M&A to build its business, and it was generally assumed that more deals would ...

MassDevice: The Bulls May Have Run A Little Too Far With St. Jude Medical

Combine a bull market with increasing optimism that major med-tech markets are stabilizing, and it's not so hard to see why stocks like...

MassDevice: Can C.R. Bard Use A Windfall To Reignite Growth?

C.R. Bard (NYSE: BCR ) has a problem; specifically, a growth problem. While the company has #1 or #2 market share in markets that make up...

MassDevices: Boston Scientific May Finally Be On The Right Path Again

It feels like Boston Scientific (NYSE: BSX ) has spent the majority of the past decade in a perpetual limbo of ineffectual turnaround. Th...

MassDevice: Can Johnson & Johnson Fire On All Cylinders Again?

In what has become a red-hot stock market for med-tech stocks, it's the rare quality company that hasn't taken part in the rally. ...

MassDevice: Edwards Lifesciences Comes Back Down To Earth ... Hard

Although I had been writing for some time that I thought Edwards Lifesciences (NYSE: EW) was significantly overvalued by the market, I do...

Investopedia: Medtronic Still Reporting Weak Growth, But A Relatively Rare Bargain

Bargains are getting harder and harder to find in the med-tech sector these days, and with Medtronic (NYSE: MDT ) sporting a double-digit E...

Investopedia: Broad Weakness Makes It Harder To Like St. Jude Today

I've been relatively optimistic about St. Jude Medical 's (NYSE: STJ ) long-term prospects as the company navigates its current mul...